GeneticTechnologies-Logo-SmallUse-RGB.jpg
Genetic Technologies’ COVID-19 Risk Test Approved for Commercial Release
April 26, 2021 08:00 ET | Genetic Technologies Ltd
MELBOURNE, Australia, April 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business...
GeneticTechnologies-Logo-SmallUse-RGB.jpg
Genetic Technologies appoints Mike Tonroe as CFO
April 12, 2021 08:15 ET | Genetic Technologies Ltd
MELBOURNE, Australia, April 12, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), announces the appointment of Michael Tonroe...
GeneticTechnologies-Logo-SmallUse-RGB.jpg
Genetic Technologies Provides Update on COVID-19 Risk Test Launch
April 09, 2021 11:15 ET | Genetic Technologies Ltd
MELBOURNE, Australia, April 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business...
GeneticTechnologies-Logo-SmallUse-RGB.jpg
Genetic Technologies Signs Multi-Year US Distribution Agreement for COVID Risk Test
March 04, 2021 07:00 ET | Genetic Technologies Ltd
MELBOURNE, Australia, March 04, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI-driven preventative health business is...
GeneticTechnologies-Logo-SmallUse-RGB.jpg
Genetic Technologies Limited Interview to Air on Bloomberg TV in the US on the RedChip Money Report®
February 26, 2021 09:20 ET | Genetic Technologies Ltd
MELBOURNE, Australia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today...
GeneticTechnologies-Logo-SmallUse-RGB.jpg
Genetic Technologies Announces Closing of $6.56 Million Registered Direct Offering
January 25, 2021 16:00 ET | Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today...
GeneticTechnologies-Logo-SmallUse-RGB.jpg
Genetic Technologies Announces $6.56 Million Registered Direct Offering
January 21, 2021 11:30 ET | Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today...
GeneticTechnologies-Logo-SmallUse-RGB.jpg
Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing
January 21, 2021 07:00 ET | Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market on...
GeneticTechnologies-Logo-SmallUse-RGB.jpg
Genetic Technologies Secures US and ANZ Distribution Rights for PREDICTIX
December 02, 2020 09:00 ET | Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, the ‘Company’), announced today that they have entered into a...
GeneticTechnologies-Logo-SmallUse-RGB.jpg
Genetic Technologies Interview Aired on Bloomberg International on the RedChip Money Report
November 23, 2020 16:30 ET | Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce an interview with its...